Structured Peer Support Program for End Stage Kidney Disease Patients
This study aims to provide supportive care through a structured peer support program for patients with end-stage kidney disease, measuring the number of patients who receive peer mentor visits and express interest in continuing, as well as the number of patients who register, complete training, and meet with at least one mentee as a mentor.
Mentoring
Urogenital Diseases+10
+ Chronic Disease
+ Female Urogenital Diseases and Pregnancy Complications
Supportive Care Study
Summary
Study start date: June 6, 2022
Actual date on which the first participant was enrolled.This study focuses on the benefits of peer mentoring for patients with End Stage Kidney Disease. Many patients discover their kidney failure unexpectedly, and this can be a challenging experience. The study aims to test the effectiveness of a structured peer support program, specifically designed for this community. The goal is to understand how patients engage with this program, their level of interest, and the perspectives of both patients and staff towards it. In this study, patients starting dialysis or those already on dialysis who need peer support are identified by the clinical team. They receive an introductory visit from a peer mentor. The study measures the number and proportion of these patients who show interest in continuing with more peer mentoring visits. Additionally, the study tracks the number of patients who register to become mentors, the percentage of those who complete mentor training, and the percentage of trained mentors who meet at least one mentee.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.57 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Mentor Patient Participants Inclusion criteria: * Patients living with dialysis or kidney transplant, who volunteer to support other patients. * Mentor participants agree to complete the CMS End Stage Renal Disease Network Peer Mentoring training program (https://www.kidneylearninghub.com/patients-peer-mentoring-program/ ) and follow the guidelines for participation in the program. Mentor Patient Participants Exclusion criteria: * Age \<18 years. * Patient cannot communicate in English. * Concerns raised by the clinical team that may expose the mentor, mentee, staff, or the program to risks, as identified by the clinical team and discussed with the principal investigator. Mentee Patient Participants Inclusion criteria: * All incident (new) dialysis patients or their care partners, within the first three months of dialysis. OR * Prevalent dialysis patients or their care partners identified by the clinical team to need peer support. Mentee Patient Participants Exclusion criteria: * Age \< 18 years. * Significant physical or psychological health conditions (including cognitive impairment) that would limit the patient's ability to interact with the mentor, AND care partner not available or reachable to join the program. * This criteria will be subjectively evaluated by the clinical team. Clinical and administrative staff supporting the program inclusion criteria * referring physicians, the medical director of the center, social workers, nurses, patient care technicians (PCT), certified clinical hemodialysis technicians (CCHT), and administrative staff. * Support staff are those who interact with mentors or mentees as part of their routine work. * Formally participate in supporting the program by identifying candidates, introducing them to the program, or providing them with support.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Satellite Healthcare Mountain View
Mountain View, United StatesOpen Satellite Healthcare Mountain View in Google MapsWellBound Mountain View
Mountain View, United States